ND-646 是乙酰辅酶 A 羧化酶（ACC）抑制剂，对重组 hACC1 和 hACC2的IC50分别为 3.5 nM 和 4.1 nM。

ND-646 is an orally bioavailable and allosteric inhibitor of the ACC enzymes ACC1 and ACC2(IC50s of 3.5 nM and 4.1 nM for recombinant hACC1 and hACC2, respectively)

ND-646-an allosteric inhibitor of the ACC enzymes ACC1 and ACC2 that prevents ACC subunit dimerization-to suppress fatty acid synthesis in vitro and in vivo.?Chronic ND-646 treatment of xenograft and genetically engineered mouse models of NSCLC inhibited tumor growth.?When administered as a single agent or in combination with the standard-of-care drug carboplatin, ND-646 markedly suppressed lung tumor growth in the Kras;Trp53-/- (also known as KRAS p53) and Kras;Stk11-/- (also known as KRAS Lkb1) mouse models of NSCLC.

1434639-57-2

C28H32N4O7S

568.64

DMSO:95 mg/mL (167.06 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years